Canada· CA-DIN-02347091
SANDOZ VALACYCLOVIR
A valaciclovir product containing valacyclovir (valacyclovir hydrochloride monohydrate), registered in Canada by SANDOZ CANADA INCORPORATED. The same ATC class is registered in 18 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Valaciclovir is registered in 18 of 19 countries.
Countries holding a registration under ATC J05AB11 (valaciclovir), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 11 of them publish a price we can compare per daily dose
Valaciclovir · ATC J05AB11
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of valaciclovir costs, country by country.
Normalised to the WHO defined daily dose (3 g), the median price runs from $1.30 in United States to $12.40 in Switzerland — a ×9.6 gap.
- 5 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Valaciclovir · price per daily dose (3 g)
USD · FX 28 Sept 2026
- CH Switzerland$12.40
- IT Italy$9.73
- ES Spain$7.89
- FR France$4.81
- US United States$1.30 (acquisition cost)
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE MONOHYDRATE)
- Manufacturer
- SANDOZ CANADA INCORPORATED
- Country
- Canada (CA)
- ATC code
- J05AB11
- ATC class
- Valaciclovir
- Defined daily dose
- 3 g, O
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
226 interactions on record for valaciclovir.
Graded by severity as the source publishes them — 16 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Valaciclovir · interactions on record
226 records
- 16 severe
- 29 moderate
- 2 minor
- 178 info
Most severe, free to view
- TemsirolimusL01EG01severe
- EverolimusL01EG02severe
- SirolimusL01EG04severe
- TemsirolimusL01XE09severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Valaciclovir in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomValaciclovir 500mg tabletsDowelhurst Ltd
- United StatesValacyclovirChartwell RX, LLC
- NorwayValaciclovir orionOrion Pharma
- CzechiaVALACICLOVIR +PHARMA+pharma arzneimittel gmbh, Graz
- SwitzerlandValaciclovir Sandoz 1000 mg, FilmtablettenSandoz Pharmaceuticals AG
- FinlandFlushnilSandoz A/S
- SpainTRIDIAVIR 1000 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFGLaboratorios Serra Pamies S.A.
- SwedenValaciclovir Actavis 500 mg Filmdragerad tablettActavis Group PTC ehf.
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Valaciclovir Actavis, Valaciclovir Allen
- Belgium · Valaciclovir Ab, Valaciclovir Sandoz
- Bulgaria · Валтрекс
- Cyprus · Valtrex
- Czechia · Valaciclovir +pharma, Valacilovir Viatris
- Germany · Valaciclovir 1 A Pharma, Valaciclovir Aurobindo
- Denmark · Valaciclovir "sandoz", Valaciclovir 1a Farma
- Estonia · Valaciclovir Actavis, Valtrex
- Spain · Tridiavir, Valaciclovir Almus
- Finland · Flushnil, Valaciclovir Ratiopharm
- France · Valaciclovir Almus, Valaciclovir Arrow
- United Kingdom (Northern Ireland) · Valaciclovir Accord Healthcare, Valaciclovir Aristo
- Greece · Valomed, Valtrex
- Ireland · Valaciclovir Accord Healthcare Ireland, Valaciclovir Bluefish
- Iceland · Valablis Forte, Valablis Normal
- Italy · Talavir, Valaciclovir Aurobindo
- Lithuania · Valaciclovir Actavis, Valtrex
- Luxembourg · Zelitrex
- Latvia · Valaciclovir Actavis, Valtrex
- Netherlands · Valaciclovir Focus, Valaciclovir Hydrochloride Hydrate Aurobindo
- Norway · Valaciclovir Sandoz, Valaciclovir Viatris
- Poland · Vaciclor
- Portugal · Valaciclovir Arpedex, Valaciclovir Aurobindo
- Romania · Valaciclovir Arena, Valtrex
- Sweden · Valaciclovir Actavis, Valaciclovir Bluefish
- Slovenia · Valtrex
- Slovakia · Valtrex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/570a51df-2f9b-40f9-bbc3-ac8faef2acda GET /v1/drugs/570a51df-2f9b-40f9-bbc3-ac8faef2acda?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02347091",
"form": "TABLET",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "J05AB11",
"schedule": [
"Prescription"
],
"drug_code": "83249",
"strengths": [
"500 MG"
],
"ahfs_class": null,
"substances": [
"VALACYCLOVIR (VALACYCLOVIR HYDROCHLORIDE MONOHYDRATE)"
],
"product_categorization": null
}See everything about valaciclovir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.